Background: The purpose of this study is to investigate the occurrence of esotropia accompanying early presbyopia. The two primary long-term mechanisms for maintenance of ocular alignment are vergence adaptation (neurologic) and muscle length adaptation (anatomic). Both mechanisms depend upon disparity-driven motor fusion for proper operation. A possible cause for an esotropic shift in early presbyopic adults with insufficient or absent disparity-driven motor fusion is inappropriate muscle length adaptation (medial rectus muscle shortening) occurring in response to increased convergence tonus accompanying increased accommodative effort.
Methods: Of 617 patients, age 10 and older who underwent surgery for esotropia during the period of 1980 to 1996, the age when the deviation occurred or worsened could be determined with confidence in 140. A plot was made of the number of these patients versus the age of onset of the deviation. This was compared with a similar plot of patients operated for exotropia.
Results: A statistically significant increase (P = 0.017) in the incidence of an esotropic shift in the age range from 30 to 50 years was found when compared with the incidence of an exotropic shift.
Conclusion: If the postulated mechanism is correct, full correction of any hyperopia as well as prompt prescription of a reading add (or conversion to monovision correction) may help prevent further progression of small esodeviations accompanying early presbyopia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jaapos.2005.06.008 | DOI Listing |
Sci Rep
December 2024
Huai'an TCM Hospital Affiliated to Nanjing University of Chinese Medicine, 3 HePing Road, Qing He Distinct, Huai'an, Jiangsu, 223002, China.
Adv Ophthalmol Pract Res
September 2024
Department of Ophthalmology, Hospital of Lithuanian University of Health Sciences, Kaunas Clinics, Kaunas, Lithuania.
Background: Presbyopia, a common age-related condition affecting near vision, impacts over a billion people worldwide. The aim of this paper is to review the main reports and results of clinical trials, comparing the newest pharmacological treatment options for presbyopia, their mechanisms of action, and possible side effects.
Main Text: Pharmacological approaches, involving eye drops that target the underlying mechanisms of presbyopia, have gained growing interest.
J Clin Med
September 2024
Chukyo Eye Clinic, Nagoya 456-0032, Japan.
Glaucoma medication may accelerate the progression of presbyopia. The aim of this study was to compare presbyopia between controls and patients with glaucoma in their 40s. This was a cross-sectional study of bilateral phakic participants aged between 40 and 49, which included controls ( = 114, mean age 46.
View Article and Find Full Text PDFGraefes Arch Clin Exp Ophthalmol
September 2024
Department of Ophthalmology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Polypseudophakia, the concept of using a second intraocular lens (IOL) to supplement an IOL that has already been placed in the capsular bag, was first used as a corrective measure where the power requirement was higher than that of available single IOLs. Subsequently, the technique was modified to compensate for post-operative residual refractive errors. In these early cases, an IOL designed for the capsular bag would be implanted in the sulcus.
View Article and Find Full Text PDFEye Contact Lens
November 2024
Department of Optometry, Eulji University, Seoul, Republic of Korea .
Objectives: The aim of this study was to evaluate the impact of wearing center-near (CN) and center-distance (CD) multifocal contact lenses (MFCLs) on spherical aberrations and visual acuity in patients with early presbyopia.
Methods: Fifty participants with early presbyopia wore CN-MFCLs and CD-MFCLs for 1 week. The average corrected refractive power was -2.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!